# INVOKANA

NDC: 50090-5029
Generic name: canagliflozin
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130329

FDA application: NDA204042

## Active ingredients

- CANAGLIFLOZIN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-5029"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-5029
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e946ba3-02c4-4a10-9d5e-f2d87b534dc3